NorthCoast Asset Management LLC boosted its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 26.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 92,952 shares of the medical device company’s stock after purchasing an additional 19,691 shares during the period. NorthCoast Asset Management LLC owned about 0.52% of Orthofix International N.V. worth $4,320,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Mason Street Advisors LLC purchased a new position in Orthofix International N.V. in the first quarter worth $159,000. State of Alaska Department of Revenue boosted its position in Orthofix International N.V. by 79.3% in the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after purchasing an additional 1,571 shares during the last quarter. Quantbot Technologies LP purchased a new position in Orthofix International N.V. in the first quarter worth $175,000. BNP Paribas Arbitrage SA boosted its position in Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after purchasing an additional 1,900 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan purchased a new position in Orthofix International N.V. in the second quarter worth $196,000. 94.43% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/09/09/orthofix-international-n-v-ofix-shares-bought-by-northcoast-asset-management-llc.html.
Several research firms have weighed in on OFIX. BidaskClub raised Orthofix International N.V. from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Jefferies Group LLC reissued a “buy” rating and issued a $55.00 price objective (up previously from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Zacks Investment Research raised Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price objective on the stock in a research report on Thursday, August 10th. Finally, BTIG Research began coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price objective on the stock. Seven equities research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average price target of $52.75.
In other Orthofix International N.V. news, insider Raymond Fujikawa sold 6,364 shares of the stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $47.06, for a total transaction of $299,489.84. Following the sale, the insider now directly owns 31,084 shares in the company, valued at approximately $1,462,813.04. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Brad Mason sold 2,733 shares of the stock in a transaction on Monday, August 21st. The shares were sold at an average price of $48.10, for a total value of $131,457.30. Following the sale, the chief executive officer now owns 188,053 shares in the company, valued at $9,045,349.30. The disclosure for this sale can be found here. Company insiders own 5.60% of the company’s stock.
Orthofix International N.V. (OFIX) traded up 0.53% on Friday, reaching $49.39. The company’s stock had a trading volume of 62,228 shares. The stock has a market cap of $897.42 million, a PE ratio of 115.67 and a beta of 0.22. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $50.40. The company’s 50 day moving average price is $47.04 and its 200-day moving average price is $42.49.
Orthofix International N.V. (NASDAQ:OFIX) last issued its earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The business had revenue of $108.90 million for the quarter, compared to the consensus estimate of $102.94 million. During the same period last year, the business posted $0.41 EPS. The company’s revenue was up 4.6% compared to the same quarter last year. On average, equities analysts expect that Orthofix International N.V. will post $1.56 EPS for the current year.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.